Introduction:

Stem Cell Therapy Market was valued at US$ 8.5 billion in 2024 and is projected to grow at a CAGR of 32.10% to reach US$ 137.5 billion by 2034.

Stem cell therapy is the treatment of various disorders or uses to treat or prevent diseases. It can prevent and treat the 80 disorders including degenerative disorder and neuromuscular. Stem cells therapy is also called as regenerative medicines treatment. There are 3 types of stem cell adult stem cells, embryonic stem cells, and induced pluripotent stem cells. Stem cells are the cells which have unique ability to replace the damaged cells and regenerate the cells and tissues.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Increasing awareness towards the therapeutics potency stem cells in giving proper treatment choices for a range of wide diseases which is the major driving factor for the growth of the stem cell therapy market. Additionally, the rising importance of regenerative medicine all over the globe and developing advanced cell therapy products based on stem cells is the boosting factor for the growth of the target market. For instance, in 2014, the NIH (National Institute of Health) at the University of California, San Diego (UCSD) Health System declared the launch of a clinical trial to evaluate the safety of neural stem cell-based therapy in patients with the chronic spinal cord injury. Moreover, by using stem cell therapy the diseases such as spinal cord injury, burns, stroke, heart diseases, macular degeneration, rheumatoid arthritis, osteoarthritis, and diabetes are treated. However, the treatment using stem cell therapy is costly, thus, the major restraining factor for the growth of the market. Nevertheless, increasing focus on the research and development of stem cells therapy can create an opportunity for the growth of the target market.

The stem cell therapy market is segmented based on treatment type, cell source, indication, and region.

Based on treatment type, the stem cell therapy market is segmented into allogenic treatment and autologous treatment. Based on the cell source, the target market is segmented into bone marrow & peripheral blood, adipose tissue, placenta & umbilical cord, embryo, and others. Based on indication, the market is classified into orthopaedic & dental, wound & injuries, cardiology & neurology, immunology and inflammatory, oncology & metabolism, and others.

Regional Insights:

Based on the region the stem cell therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the North America region is dominating the target market due to the presence of a strong investment in regenerative medicine sector and healthcare infrastructure. Additionally, the Europe region shows a significant growth in the market due to rising research and increasing the investment in the target market.  Moreover, investments into research and development for better healthcare is anticipated to create growth opportunities for the Asia Pacific stem cell therapy market.

Report Scope:

Attribute	Details
Market Size 2024	US$ 8.5 billion
Projected Market Size 2034	US$ 137.5 billion
CAGR Growth Rate	32.10%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Treatment Type - Allogenic Treatment and Autologous Treatment By Cell Source - Bone Marrow & Peripheral Blood, Adipose Tissue, Placenta & Umbilical Cord, Embryo, and Others By Indication - Orthopaedic & Dental, Wound & Injuries, Cardiology & Neurology, Immunology and Inflammatory, Oncology & Metabolism, and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Stem Cell Therapy Market report based on treatment type, cell source, indication, and region.

Stem Cell Therapy Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the stem cell get to market involves Osiris Therapeutics, Inc., ANTEROGEN.CO. LTD., Athersys Inc., CORESTEM, Inc., JCR Pharmaceuticals Co., Ltd., Mesoblast Ltd., NuVasive, Inc., Orthofix Holdings, Inc., Osiris Therapeutics, Inc., Reliance Life Sciences Private Limited. Prominent players operating in the target market are focusing on strategic partnerships as well as launching various treatment types to gain a competitive edge in the target market. In 2018, Osiris Therapeutics, Inc. dominated the target market, with all over-contribution 17.6% of the product of the stem cell therapy market size.

• Osiris Therapeutics, Inc. *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• ANTEROGEN.CO. LTD.
• Athersys Inc.
• CORESTEM, Inc.
• JCR Pharmaceuticals Co., Ltd.
• Mesoblast Ltd.
• NuVasive, Inc.
• Orthofix Holdings, Inc.
• Osiris Therapeutics, Inc.
• Reliance Life Sciences Private Limited

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Industry Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for Stem Cell Therapy Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Treatment Type
     • Market Snippet, By Cell Source
     • Market Snippet, By Indication
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Treatment Type, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Allogenic Treatment
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Autologous Treatment
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
6. Market Segmentation, By Cell Source, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Bone Marrow & Peripheral Blood
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Adipose Tissue
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Direct Placenta & Umbilical Cord
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Embryo
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
7. Market Segmentation, By Indication, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Aero Orthopaedic & Dental
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Wound & Injuries
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Cardiology & Neurology
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Immunology and Inflammatory
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Oncology & Metabolism
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
8. Global Market, By Region, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Treatment Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Cell Source, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Indication, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Treatment Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Cell Source, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Indication, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Treatment Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Cell Source, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Indication, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • China
       • India
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Treatment Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Cell Source, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Indication, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Treatment Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Cell Source, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Indication, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
9. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
10. Company Profiles
    • • Osiris Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • ANTEROGEN.CO. LTD.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Athersys Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • CORESTEM, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • JCR Pharmaceuticals Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      •  Mesoblast Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • NuVasive, Inc. 
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Orthofix Holdings, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Osiris Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Reliance Life Sciences Private Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
11. The Last Word
    • Future Impact
    • About Us
    • Contact